The global fertility drugs market is anticipated to grow at a substantial CAGR of around 5.1% during the forecast period (2022-2028). The increasing average age of conceiving, changing lifestyle and cultural shifts, rising prevalence of polycystic ovarian syndrome among the younger women, and government policies and schemes for infertility treatment are factors that drive the growth of the global fertility drug market. For instance, according to Kaiser Family Foundation, the US government has supported family planning and reproductive health by funding $608 million including funding for United Nations Population Fund (UNFPA) in 2020, which is up from $425 million in 2006. Additionally increasing investment by pharma companies in fertility treatment centres will further boost the growth of the market. For instance, in June 2021, Invo Bioscience Inc. signed a joint venture agreement in partnership with INVO centers LLC to open Invo clinics in Atlanta. These clinics through the utilization of the INVOcell technology bring advanced fertility care and provide access to the millions of underserved people. Moreover, the clinics democratize fertility care, lowering key barriers and providing help for fertility care to start a family.
Browse the full report description of “Global Fertility Drugs Market Size, Share & Trends Analysis Report by Gender Type (Female Fertility Treatment, Male Fertility Treatment) by Treatment Type (Hormonal, In Vitro Fertilization(IVF), Intra Cytoplasmic Sperm Injection(ICSI), Intrauterine Insemination(IUI), Alternative and Complementary Treatment) by Infertility Type (Problem With Ovulating, Unexplained Infertility, Blocked Or Damaged Tubes, Endometriosis, Polycystic Ovarian Syndrome) Forecast 2022-2028” at https://www.omrglobal.com/industry-reports/fertility-drugs-market
Moreover, the increasing prevalence of obesity and higher consumption of smoking and alcohol results in a lower fertility rate in women. According to FDA, every year nearly 400,000 US infants are exposed to cigarette smoke and its chemicals in the womb, this leads to an increase in the risk of lungs that fail to develop properly, birth defects such as cleft lip and cleft palate, and sudden infant death syndrome(SIDS).
Market Coverage
• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
o By Gender Type
o By Treatment Type
o By Infertility Type
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- F. Hoffmann-La Roche Ltd., Ferring Pharmaceuticals Inc., Johnson & Johnson Pvt. Ltd., Leadiant Biosciences Inc., and Merck & Co. Pharmaceutical Co., Noven Pharmaceutical organon, Inc., Pfizer Inc., and others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Fertility Drug Market Segment
By Gender Type
• Female Fertility Treatment
• Male Fertility Treatment
By Treatment Type
• Hormonal
• In Vitro Fertilization(Ivf)
• Intra Cytoplasmic Sperm Injection(Icsi)
• Intrauterine Insemination(Iui)
• Alternative and Complementary Treatment
By Infertility Type
• Problem with Ovulating
• Unexplained Infertility
• Blocked or Damaged Tubes
• Endometriosis
• Polycystic Ovarian Syndrome
Global Fertility Drug Market Report by Region
North America
• US
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/fertility-drugs-market